Skip to content

Capricor Therapeutics, Inc.

CAPR· NasdaqCore metricsCIK 1133869

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -8.70%
Market cap
$595.08M
58.14M shares
Filings
967
$0.00
FY 2025−100.0% FY25 yoy
-$42.66M
Q3 2026N/M FY25 yoy
-$44.68M
Q3 2026N/M FY25 yoy
-$107.42M
Q3 2026derivedN/M FY25 yoy
-$0.73
Q3 2026N/M FY25 yoy
$44.28M
Q3 2026+2,450.3% FY25 yoy
$595.08M
—
—
2.8×
-12.22%
—

FY2025 figures · derived

Price

$10.24+65.08%+$4.03past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$25.18M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$22,270,465reported
FY 20232023-12-31$25,178,066reported
FY 20222022-12-31$2,600,000reported
FY 20212021-12-31$244,898reported
FY 20202020-12-31$310,250reported
FY 20192019-12-31$1,005,028reported
FY 20182018-12-31$1,671,356reported
FY 20172017-12-31$2,666,340reported
FY 20162016-12-31$3,998,618reported
FY 20152015-12-31$5,517,648reported
FY 20142014-12-31$4,786,700reported

Capital returns

Dividends and buybacks · FY2018 to FY2020
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2020—$0.00$0.00—22.80M sh+155.9%—
FY2019—$193.00$193.00—8.91M sh−73.5%—
FY2018—$0.00$0.00—33.66M sh+21.5%—

Pharmaceutical preparations

Capricor Therapeutics, Inc. is the 179th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Capricor Therapeutics, Inc. · CIK 1133869 · Engraved from SEC EDGAR